SCHEMBL4903696

SCHEMBL4903696

CC(C)(C)c1ccc(O)c(NC(=O)CCN2C(=O)c3ccccc3C2=O)c1.CC(C)(C)c1ccc2oc(CCN3C(=O)c4ccccc4C3=O)nc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
HPGD P15428 1/20 0.45
PPARG P37231 1/20 0.45
RAB9A P51151 1/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
HSD17B10 Q99714 1/20 0.41
PDE4B Q07343 5/20 0.41
POLB P06746 1/20 0.41
ADORA2A P29274 1/20 0.40
PDE7A Q13946 3/20 0.40
HTR1A P08908 2/20 0.40
HTR7 P34969 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904079 0.85 MEN1 (0.50) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4897967 0.85 MAPT (0.44) KMT2AALDH1A1MAPTSMN1; SMN2KDM4E
SCHEMBL4906852 0.85 MEN1 (0.58) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4905835 0.71 PKM (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL4903614 0.69 ALDH1A1 (0.54) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4906117 0.69 MAPT (0.60) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4905954 0.69 PDE10A (0.48) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL4905164 0.63 LOXL2 (0.55) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL7512433 0.63 POLB (0.41) KMT2AALDH1A1MAPTSMN1; SMN2KDM4E
SCHEMBL11735860 0.62 ESR1 (0.53) MEN1KMT2AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MEN1 4859/4885KMT2A 3602/4885ALDH1A1 2664/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.